KK

Kannan Krishnamurthy

Active Director Director DIN 00547013
DIN 00547013 First appointment Jul 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jul 2002
Shareholding value •••• Premium profile

About Kannan Krishnamurthy

Data last updated:

Kannan Krishnamurthy is a Director at Aventur Bio-Resources Private Limited (since 2008), Director at Navjeevan Lifescience Private Limited (since 2004) and Director at Sunline Gas Technologies Private Limited (since 2008), and holds 1 more current directorship. The companies operate in Pharma, Automobile and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹8.28 Cr; the largest is Aventur Bio-Resources Private Limited at ₹5.28 Cr (FY 2015). Earlier, Kannan Krishnamurthy was a Director at Lord Lifescience Private Limited (2013–2014) and Additional Director at Manvee Impex Private Limited (2010).

DIN 00547013
Primary Designation Director
Industry Pharma
First Appointment 27 Jul 2002
Oldest Company Age 26 yrs
Largest company Aventur Bio-Resources Private Limited · ₹5.28 Cr (FY 2015)
Combined revenue ₹8.28 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Sep 20082005₹5.28 Cr (FY 2015)Active
Director16 Feb 20042002₹3.00 Cr (FY 2015)Active
Director01 Jan 20082000Active
Sunline Impex Private Limited U51909MH2002PTC136602
Director27 Jul 20022002Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lord Lifescience Private Limited U17100MH2010PTC204901
Director28 Aug 20132010₹4.09 Cr (FY 2024)Active
Manvee Impex Private Limited U24100MH2009PTC192062
Additional Director19 Jan 20102009₹3.25 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aventur Bio-Resources Private Limited
Sunline Gas Technologies Private Limited
Navjeevan Lifescience Private Limited
Sunline Impex Private Limited
Premium access

Shareholding and investment profile for Kannan Krishnamurthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kannan Krishnamurthy

Kannan Krishnamurthy currently holds 4 directorships: Aventur Bio-Resources Private Limited (Director, since 12 Sep 2008, revenue ₹5.28 Cr (FY 2015)); Navjeevan Lifescience Private Limited (Director, since 16 Feb 2004, revenue ₹3.00 Cr (FY 2015)); Sunline Gas Technologies Private Limited (Director, since 01 Jan 2008); Sunline Impex Private Limited (Director, since 27 Jul 2002).

Kannan Krishnamurthy was first appointed on 27 Jul 2002 as Director at Sunline Impex Private Limited. The most recent appointment on record is 28 Aug 2013 at Lord Lifescience Private Limited.

The 2 current companies of Kannan Krishnamurthy that report revenue have a combined latest revenue of ₹8.28 Cr: Aventur Bio-Resources Private Limited ₹5.28 Cr (FY 2015); Navjeevan Lifescience Private Limited ₹3.00 Cr (FY 2015).

Kannan Krishnamurthy held 2 earlier board appointments: Lord Lifescience Private Limited (Director, 28 Aug 2013 to 23 Jun 2014); Manvee Impex Private Limited (Additional Director, 19 Jan 2010 to 30 Sep 2010).

The current boards of Kannan Krishnamurthy's companies include Harshad Champaklal Shah (Aventur Bio-Resources Private Limited), Rajendra Chandrakant Potnis (Aventur Bio-Resources Private Limited), Bakul Pandharinath Patil (Navjeevan Lifescience Private Limited), Mahalakshmi Krishnamurthy (Sunline Gas Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available